Company Filing History:
2 out of 2 
2 out of 32 
2 out of 2 Years Active: 2009-2011
Title: The Innovative Contributions of Barry John Allen
Introduction
Barry John Allen, an esteemed inventor based in Yowie Bay, Australia, has made significant strides in the field of cancer treatment through his innovative patents. With a total of three patents to his name, his work emphasizes the use of advanced methodologies and conjugates to enhance cancer detection and treatment.
Latest Patents
One of his notable patents is for "PAI-2 conjugates for the treatment and imaging of cancer." This groundbreaking method focuses on detecting, visualizing, and treating cancerous cells that express a uPA/uPAR complex. The approach utilizes a PAI-2 conjugate molecule, which comprises PAI-2 or its functional derivatives, linked to a toxin or label, thereby aiding in effective cancer therapies.
Another significant invention is the "Radioimmunoconjugates for targeted alpha therapy." This patent features a radioimmunoconjugate that combines an alpha-emitter, such as Bi-213, with the monoclonal antibody C595. The wide applicability of this innovation in cancer therapy makes it particularly effective for treating pancreatic and prostate cancers, as well as breast and ovarian cancers.
Career Highlights
Barry John Allen's career has been marked by his impactful contributions to medical science. He has worked for renowned organizations, including Pai-2 Pty Limited, where his projects further pushed the boundaries of cancer research and treatment. Additionally, his association with the University of Wollongong has allowed him to collaborate with academia to enhance the practical applications of his inventions.
Collaborations
Throughout his career, Barry has collaborated with several notable individuals, including his coworkers Marie Ranson and Clive Leighton Bunn. These partnerships have fueled innovation and provided collective expertise in the advancement of cancer treatment technologies.
Conclusion
In summary, Barry John Allen stands out as an influential inventor who has dedicated his efforts to combatting cancer through innovative methodologies. With his latest patents, he continues to bridge the gap between research and practical application, setting a strong foundation for future advancements in oncological therapies.